Anti-tuberculosis 4FDC tablets--mystery to chemistry.
Dekker
Theo G
TG
Lötter
Antoni P
AP
D000904:Antibiotics, Antitubercular / Q000008:administration & dosage / Q000737:chemistry* / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000737:chemistry* / Q000627:therapeutic use*; D004338:Drug Combinations; D004355:Drug Stability; D004356:Drug Storage; D004977:Ethambutol / Q000008:administration & dosage / Q000737:chemistry* / Q000627:therapeutic use*; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000737:chemistry* / Q000627:therapeutic use*; D011718:Pyrazinamide / Q000008:administration & dosage / Q000737:chemistry* / Q000627:therapeutic use*; D012293:Rifampin / Q000008:administration & dosage / Q000737:chemistry* / Q000627:therapeutic use*; D013607:Tablets; D014376:Tuberculosis / Q000188:drug therapy*
D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D004338:Drug Combinations; D013607:Tablets; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin